Highlights from the American Academy of Neurology Annual Meeting 2026
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Highlights from the American Academy of Neurology Annual Meeting 2026
-
ナレーター：
-
著者：
In this episode of Meeting Mic, we bring you pearls and perspectives from the American Academy of Neurology (AAN) Annual Meeting 2026.
Christopher Lock, MD, discusses key takeaways from the meeting. 00:12
Claire Delpirou Nouh, MD, highlights the meeting's major discussions and presentations. 05:27
Top headlines from the meetings. 08:42
Read the full coverage here:
Improved mortality outweighs cognitive risks in GLP-1 analog use
Source: Thorman IB, et al. Long-term risk of cognitive impairment with GLP-1 analogues in older adults with type 2 diabetes mellitus. Presented at: American Academy of Neurology Annual Meeting; April 5-9, 2025; San Diego.
Prolonged seizures negatively impact productivity, quality of life in patients, caregivers
Source: Trinka E, et al. Loss of productivity, seizure worry, and patient and caregiver quality of life associated with prolonged seizures: Results from a global real-world point-in-time study. Presented at: American Academy of Neurology Annual Meeting; April 18-22, 2026; Chicago.
Improvements in biological age linked to lower stroke risk, healthier brains
Source: Rivier C, et al. Improvements in biological age acceleration lead to better neuroimaging, clinical and cognitive markers of brain health. Presented at: American Academy of Neurology Annual Meeting; April 5-9, 2025; San Diego.